Related Experiment Videos
Evaluation of cefaclor and amoxycillin in the treatment of acute otitis media
Abstract:
Twenty-eight patients with acute otitis media were treated in a random double blind manner with either amoxycillin or cefaclor. The predominant organisms isolated were H. influenzae and S. pneumoniae. All patients responded satisfactorily except one, treated with cefaclor, whose compliance with the regimen was very doubtful. One instance of mild elevation of SGOT and one case of mild erythematous rash occurred in each treatment group. In this limited study, cefaclor appeared comparable to amoxycillin in the treatment of acute otitis media.
Insights
Cefaclor and amoxicillin are comparable treatments for acute otitis media, a common ear infection. Both antibiotics showed high efficacy, with minimal side effects observed in this study.
Area of Science:
- Infectious Diseases
- Pharmacology
- Pediatrics
Background:
- Acute otitis media (AOM) is a common childhood infection.
- Bacterial pathogens like *Haemophilus influenzae* and *Streptococcus pneumoniae* frequently cause AOM.
- Effective antibiotic treatment is crucial for managing AOM and preventing complications.
Purpose of the Study:
- To compare the efficacy and safety of cefaclor versus amoxicillin in treating acute otitis media.
- To evaluate treatment outcomes in patients infected with common AOM pathogens.
Main Methods:
- A randomized, double-blind study involving 28 patients with AOM.
- Patients were treated with either amoxicillin or cefaclor.
- Bacterial cultures were obtained, and patient responses were monitored.
Main Results:
- Both cefaclor and amoxicillin demonstrated satisfactory treatment responses in most patients.
- One patient receiving cefaclor had a doubtful compliance, impacting the outcome.
- Mild elevations in SGOT and mild erythematous rash were reported in both groups, indicating comparable safety profiles.
Conclusions:
- Cefaclor is a viable alternative to amoxicillin for treating acute otitis media.
- Further research with larger cohorts is warranted to confirm these findings.
- Both antibiotics are generally well-tolerated with similar safety profiles in AOM treatment.